L-theanine is one of the better-tolerated dietary supplements in the research literature. Clinical trials consistently report adverse event rates comparable to placebo, and no serious adverse events have been attributed to L-theanine supplementation at standard doses. That said, “well-tolerated” does not mean “zero risk,” and certain populations should exercise caution.
Common Side Effects (Reported in <5% of Trial Participants)
The following side effects have been reported in clinical trials, though at rates that were not statistically different from placebo:
Headache. The most frequently mentioned adverse event across L-theanine trials. In the Hidese et al. (2019) four-week study, headache was reported by a small number of participants in both the L-theanine and placebo groups, with no significant difference between them (Hidese et al., 2019).
Gastrointestinal discomfort. Mild nausea, stomach upset, or loose stools have been reported occasionally. Some evidence suggests these effects are more common with L-theanine consumed as part of green tea (where tannins and catechins may contribute) than with isolated L-theanine supplements.
Dizziness. Rarely reported. This may relate to L-theanine’s modest blood pressure–lowering effect in susceptible individuals.
Uncommon and Theoretical Risks
Blood pressure reduction. L-theanine has demonstrated the ability to attenuate stress-induced blood pressure increases (Yoto et al., 2012). In isolation, this is generally considered a benefit. It becomes a risk factor for people already taking antihypertensive medications, where additive blood pressure lowering could produce symptomatic hypotension (lightheadedness, fainting, fatigue).
Enhanced sedation. While L-theanine alone does not cause sedation at typical doses, combining it with sedative drugs (benzodiazepines, barbiturates, sleep medications, or alcohol) may produce additive relaxation effects. This interaction is pharmacologically plausible based on L-theanine’s GABA-modulating activity, though it has not been formally studied in drug interaction trials.
Tolerance development. Some long-term users report that L-theanine’s subjective effects diminish over months of continuous use. This has not been rigorously studied, and the mechanism, whether receptor downregulation, pharmacokinetic adaptation, or psychological habituation, remains unknown. The clinical significance is unclear because most controlled trials are limited to 4-8 weeks.
Drug Interactions
Two interaction categories have clinical relevance:
Blood Pressure Medications
L-theanine may lower blood pressure, particularly during stress. People taking ACE inhibitors, ARBs, calcium channel blockers, beta-blockers, or diuretics should monitor for symptoms of excessive blood pressure reduction (dizziness on standing, fatigue, visual changes). This is a theoretical interaction based on L-theanine’s demonstrated hemodynamic effects, not a documented case series.
Sedatives and CNS Depressants
L-theanine’s effects on GABA and alpha brain wave activity could theoretically amplify the effects of sedative medications including benzodiazepines (lorazepam, diazepam), sleep aids (zolpidem, eszopiclone), antihistamines used for sleep, and alcohol. Concurrent use should be discussed with a healthcare provider.
Chemotherapy Agents
Limited preclinical evidence suggests L-theanine may enhance the antitumor activity of certain chemotherapy drugs while reducing their side effects. This has been studied primarily in cell culture and animal models and is not established in human oncology. People undergoing cancer treatment should consult their oncologist before adding any supplement.
Population-Specific Safety Considerations
Pregnancy and Breastfeeding
There are no controlled studies evaluating L-theanine supplementation during pregnancy or breastfeeding. L-theanine excretion into breast milk has not been studied (LactMed, 2025). The absence of data is not evidence of harm, but most healthcare providers recommend avoiding supplemental doses during pregnancy and lactation as a precautionary measure. The amounts of L-theanine consumed through moderate tea drinking (1-3 cups/day) are not typically considered a concern.
Children
L-theanine has been studied in boys aged 8-12 with ADHD at 400 mg/day for six weeks, with no significant adverse events reported (Lyon et al., 2011). This is a narrow evidence base (one condition, one age range, one sex, short duration). Pediatric use should be guided by a healthcare provider.
People with Low Blood Pressure
Individuals with baseline hypotension or orthostatic hypotension should start at a lower dose (100 mg) and monitor symptoms. L-theanine’s blood pressure effects are most pronounced during stress and are generally modest, but individual sensitivity varies.
People with Kidney or Liver Disease
L-theanine is metabolized and excreted through standard pathways. There are no published reports of L-theanine causing kidney or liver toxicity. However, people with significant impairment in either organ should discuss any supplement with their healthcare team, as altered metabolism could change the compound’s pharmacokinetics.
Toxicity Data
Animal toxicity studies indicate a wide safety margin. The acute oral maximum tolerated dose in mice exceeded 20 g/kg , hundreds of times higher than any supplemental dose. Chronic toxicity studies and carcinogenicity assessments in animals have not identified tumorigenic or organ-toxic effects at high doses (Türközü & Şanlier, 2017).
No fatal L-theanine overdoses have been reported in humans. Given the very high LD50 in animal models and the relatively low doses used in supplementation (200-900 mg), acute toxicity from L-theanine supplements is extremely unlikely.
What the Safety Evidence Does Not Cover
Most L-theanine trials are short: four to eight weeks. The longest controlled study was 12 weeks. This means:
Long-term safety beyond three months has not been established in clinical trials. People who have consumed green tea daily for decades provide indirect evidence of long-term tolerability, but tea contains many other compounds and the L-theanine dose from tea is lower than typical supplemental doses.
Interactions with many common medications have not been formally tested. The antihypertensive and sedative interactions are based on pharmacological reasoning, not dedicated interaction studies.
Effects in pregnant women, the elderly over 75, and people with multiple comorbidities are essentially unstudied.
References
-
Hidese S, et al. Effects of L-theanine administration on stress-related symptoms. Nutrients. 2019;11(10):2362. PMID: 31623400
-
Yoto A, et al. Effects of L-theanine or caffeine intake on changes in blood pressure. J Physiol Anthropol. 2012;31(1):28. PMID: 22127270
-
LactMed. Green Tea. In: Drugs and Lactation Database. Updated 2025. PMID: 30000907
-
Lyon MR, et al. Effects of L-theanine on objective sleep quality in boys with ADHD. Altern Med Rev. 2011;16(4):348-354. PMID: 22214254
-
Türközü D, Şanlier N. L-theanine, unique amino acid of tea. Crit Rev Food Sci Nutr. 2017;57(8):1681-1687. PMID: 27396868